What is BK Virus? BK Virus (BKV) is a common virus belonging to the Polyomaviridae family. Most people become infected during childhood, and the virus usually remains latent in the body without causing problems. In people with a weakened immune system, particularly after organ transplantation, the virus may reactivate and cause complications.
Why is it important in transplant patients? Reactivation of BK Virus is particularly important in patients who have undergone kidney transplantation, as it can damage the transplanted graft and affect its function. For this reason, BKV monitoring may be part of the follow-up of patients after transplantation.
How is it transmitted? BK Virus is usually transmitted during childhood and, once it enters the body, may remain latent for many years. Reactivation is mainly associated with a weakened immune system.
How is the test performed? BKV testing is usually performed using a urine or blood sample, depending on the purpose of the test. Using molecular methods such as PCR, the DNA of BK Virus can be detected and quantified.
What can the test analyze? The molecular test can determine:
When is testing recommended? Testing may be particularly recommended for:
Why is monitoring important? Early detection of an increase in viral load may allow the medical team to take measures to reduce the risk of complications associated with BKV reactivation.
The test should always be interpreted by a specialist physician, particularly in transplant patients.
BK Virus (BKV) is a common virus that can remain latent in the body without causing symptoms. In people with weakened immunity, the virus may reactivate.
BKV is particularly important in patients who have undergone kidney transplantation, as reactivation of the virus may affect graft function.
Testing is particularly recommended for:
The test can be performed using a blood or urine sample, depending on the purpose of the test. Molecular methods such as PCR are used to detect and measure the virus.
No, fasting is not required for the BKV test.
If a blood sample is collected, the procedure is similar to a routine blood test and causes only mild discomfort.
The molecular test can detect BK Virus DNA and determine the viral load, meaning the amount of virus present in the sample.
A positive result indicates that BK Virus DNA has been detected in the analyzed sample. This does not automatically mean that there is kidney damage. The physician interprets the result together with the viral load, kidney function tests, and the patient’s clinical condition.
Yes. The virus may remain latent in the body without causing symptoms. Problems mainly occur when the immune system is weakened.
In transplant patients, the physician may recommend repeated monitoring of the viral load to determine whether the virus is increasing, decreasing, or remaining stable.
A high viral load may require further evaluation by the transplant team. Depending on the situation, the physician may adjust immunosuppressive therapy or request additional tests.
No. Detection of BKV does not automatically mean that the transplant is at immediate risk. Monitoring and early intervention, when necessary, help manage the risk.
There is no standard specific antiviral treatment that directly eliminates BKV. In transplant patients, management often involves adjustment of immunosuppression by the transplant team, as appropriate for each case.
The results should be interpreted by a specialist physician or the transplant team, taking into account the viral load, graft function, and the patient’s overall condition.
